EPISODE · Apr 11, 2026 · 24 MIN
BPC-157 - Red Flags, Regulators, and the Cancer Question
from BPC-157 · host Inception Point Ai
Host Ben Synth examines BPC-157, a biohacking peptide with zero human clinical trials and an FDA Category 2 safety warning. We explore regulatory red flags, theoretical cancer risks from angiogenesis, purity concerns in unregulated markets, and why promising rodent studies don't guarantee human safety.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.
What this episode covers
Host Ben Synth examines BPC-157, a biohacking peptide with zero human clinical trials and an FDA Category 2 safety warning. We explore regulatory red flags, theoretical cancer risks from angiogenesis, purity concerns in unregulated markets, and why promising rodent studies don't guarantee human safety.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.
NOW PLAYING
BPC-157 - Red Flags, Regulators, and the Cancer Question
No transcript for this episode yet
Similar Episodes
Jul 6, 2026 ·17m
Jul 3, 2026 ·40m
Jul 1, 2026 ·32m
Jun 29, 2026 ·15m
Jun 26, 2026 ·46m
Jun 24, 2026 ·2m